ICUS Weekly News Monitor 11-16-2017

European Association of Cardiovascular Imaging 

EACVI webinar: Contrast echocardiography in daily routine practice

Thursday 23 November 2017 from 18:00 to 19:00 CET


  • Non-Invasive Imaging
  • Myocardial Disease


Join Assoc. Prof. Constantina Aggeli, Prof. Bharati Shivalkar and Dr. Andreas Helfen

Free for everyone!

By attending this webinar, participants will learn:

  • The indications of using contrast agents in clinical practice and particularly in stress echo studies
  • The role of contrast echo during stress echo protocols. What do we expect?
  • Tips and tricks in using contrast agents at rest and at peak of the stress echo protocol.
  • Cases for presentation. The evaluation of both wall motion and perfusion abnormalities.

Register now and learn more.



Clinical Practice: Review

An Introduction to Contrast-Enhanced Ultrasound for Nephrologists

Nov 9, 2017

By Chang E.H.

University of North Carolina Kidney Center, Chapel Hill, NC, USA


Contrast-enhanced ultrasound (CEUS) is an emerging technology with no known nephrotoxicity. CEUS has been utilized in cardiac and abdominal imaging for decades in Asia and Europe and has recently received greater attention in the United States with its approval for characterization of indeterminate liver lesions. Emerging data suggest that CEUS has potential as a diagnostic imaging tool among individuals who have contraindications to CT and MRI. Few nephrologists are aware of CEUS and even fewer are aware of its potential applications among individuals with kidney disease. This review introduces CEUS to the nephrology community and provides a basic overview of CEUS technology. Knowledge of the applications, advantages, and disadvantages of CEUS provides the framework for nephrologists to make informed decisions regarding this emerging imaging test in appropriate circumstances. This review focuses on the use of CEUS for the characterization of indeterminate kidney lesions and summarizes the most recent data, some of which specifically includes patients with chronic kidney disease (CKD). The results demonstrate that CEUS has high sensitivity and moderate specificity for detecting malignancy in indeterminate kidney lesions among individuals with and without CKD. In conclusion, CEUS is an emerging imaging technique that may have clinically useful applications for detecting malignant kidney lesions, specifically in patients with CKD. However, most of the current data come from small, single-center studies, and larger, multicenter studies are needed.

ICUS Sponsors

ICUS gratefully acknowledges its 2017 sponsors:






Contact ICUS

  • Address:  International Contrast Ultrasound Society
    c/o Dentons
    233 S. Wacker Drive, Suite 5900 Chicago, IL 60606-6361
  • Telephone: 202-408-6199

About ICUS

ICUS is the world’s only professional society exclusively devoted to contrast-enhanced ultrasound (CEUS) medical imaging technology.

Learn more...

You are here: Home ICUS Weekly News Monitors ICUS Weekly News Monitor 11-16-2017